Compare Edwards Lifesciences Corporation Common Stock (EW) vs Johnson Controls International PLC (JCI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Johnson Controls International PLC — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.24 (market cap $48.56B), while Johnson Controls International PLC trades at $155.13 (market cap $93.28B). The key difference: Johnson Controls International PLC is the larger of the two by market cap, and Johnson Controls International PLC pays a 1.04% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | JCI | |
|---|---|---|
Market Cap | $48.56B | $93.28B |
Volume | 6,520,488 | 2,786,476 |
Sector | Health | Basic Materials |
52-Week High | $95.18 | $158.76 |
52-Week Low | $72.65 | $105.55 |
Enterprise Value | $45.01B | $102.12B |
Typical Hold Time | — | 65 Days |
Dividend Yield | — | 1.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Johnson Controls International (JCI) trades at $155.93, down 1.78% on the day, with a bullish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with an EPS of $1.42, and raised its full-year 2026 guidance. Revenue for 2025 was $23.60B, with net income surging to $3.29B, reflecting a robust profit margin of 13.94%. Analyst sentiment is positive, with a consensus price target of $172.50 and no sell ratings among 45 analysts.
The outlook for JCI is favorable, driven by strong demand in data-center and mission-critical thermal management systems, as highlighted in recent earnings. Investment opportunities include potential upside to the consensus target and consistent dividend payments. Key risks involve elevated valuation multiples, such as a P/E of 43.92, and macroeconomic sensitivity impacting industrial demand.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Johnson Controls International PLC
Johnson Controls manufactures, installs, and services HVAC systems, building management systems and controls, industrial refrigeration systems, and fire and security solutions. Commercial HVAC accounts for about 40% of sales, fire and security also represents 40% of sales, and residential HVAC, industrial refrigeration, and other solutions account for the remaining 20% of revenue. In fiscal 2021, Johnson Controls generated over $23.5 billion in revenue.
Read more on JCI →
